Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study | Zendy

Patrick H. Pun | Zendy; Anne S. Hellkamp | Zendy; Gillian D Sanders | Zendy; John P. Middleton | Zendy; Stephen C. Hammill | Zendy; Hussein R. AlKhalidi | Zendy; Lesley H. Curtis | Zendy; Gregg C. Fonarow | Zendy; Sana M. AlKhatib | Zendy

Open Access

Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study

Author(s) -

Patrick H. Pun,

Anne S. Hellkamp,

Gillian D Sanders,

John P. Middleton,

Stephen C. Hammill,

Hussein R. AlKhalidi,

Lesley H. Curtis,

Gregg C. Fonarow,

Sana M. AlKhatib

Publication year - 2014

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfu274

Subject(s) - medicine , cohort , propensity score matching , dialysis , hazard ratio , population , cohort study , kidney disease , proportional hazards model , end stage renal disease , confidence interval , hemodialysis , environmental health

Sudden cardiac death is the leading cause of death among end-stage kidney disease patients (ESKD) on dialysis, but the benefit of primary prevention implantable cardioverter defibrillators (ICDs) in this population is uncertain. We conducted this investigation to compare the mortality of dialysis patients receiving a primary prevention ICD with matched controls.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research